Biotech & Pharma: solutions

We solve problems related to:

Advanced Therapy Medicinal Products (ATMPs)

We support the development, manufacture, quality and release of ATMPs:

  • Our core expertise is based on 25 years of experience in cell & gene therapies and tissue-engineered products (TEPs)
  • Cell therapeutics based on e.g. MSCs, IPSCs
  • Gene therapeutics such as recombinant viral vaccines or viral ophthalmic products
  • Tissue-engineered products (TEPs) such as small-caliber blood vessel surrogates, biotechnologically produced replacement tissues/tissue patches for reconstructive procedures
     

Vaccines, Gene Therapeutics,
Biologics

  • Development, Manufacturing & Quality of Vaccines/Gene Therapeutics/Biologics
  • Manual and bioreactor/single-use processes
     

Aseptic manufacturing

  • Planning and implementing processes, equipment
  • Aseptic processes for cell and gene therapeutics as well as tissue engineering products
  • Aseptic processes for vaccines, biologics
  • Training on the above topics
     

Quality assurance

  • GMP compliance
  • Inspection readiness
  • Audits, e.g. supplier audits
    • Planning, Reporting, Tracking
  • Documentation:
    • Batch Reports - creation, review
    • Procedural Instructions: preparation, review
    • Site Master Files
    • Quality Manuals
       

Quality Risk Management (QRM)

  • Quality risk processes, SOPs
  • Quality risk assessments
  • QRM Plans, Reports
  • Risk mitigation measures
     

Product Release/ Qualified Person Services

  • We are active as a Qualified Person in both Germany and Great Britain
  • with 25 years of experience and a profound scientific insight in complex biologics and related, we offer sound decision making, also in non-trivial situations

Statistical support

Statistical Analysis & Risk Assessment
We support e.g. pharmaceutical and biotechnology projects in the statistical evaluation of quality, process and scientific data as well as in data-based decisions. 
 

  • Data distribution & variability – Are contamination values, analysis results or process parameters within the expected range or is there a noticeable change? 
  • Probability & Risk Assessment – What is the probability that a critical parameter will exceed a defined threshold? 
  • Specifications & Acceptance Criteria – Does a product or process meet a defined criterion with sufficient statistical certainty? 
  • Comparison of processes or conditions – Is the difference between processes, batches, suppliers or conditions statistically relevant? 
  • Trend analysis – Does the data show a systematic change or a possible trend? 
  • Outlier assessment – Is an abnormal value an isolated case or a possible signal of a systematic problem? 
  • Confidence intervals & uncertainty – How reliable is the statistical statement and how great is the remaining uncertainty? 
  • Data Visualization & Interpretation – How can complex data be presented in an understandable way and used for quality and project decisions? 


Goal: To convert complex data into a comprehensible quantitative basis for quality, risk and process decisions.
 

Plant design

  • Functional plant layouts for aseptic production
    • of biologics, vaccines, parenterals, ATMPs
    • at pilot or commercial scale
  • Facilities for compliant handling genetically modified organisms
     
Information icon

Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen

Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.